Literature DB >> 30682699

Insulin-like growth factor 1 promotes cochlear synapse regeneration after excitotoxic trauma in vitro.

Kohei Yamahara1, Nakarin Asaka2, Tomoko Kita3, Ippei Kishimoto3, Mami Matsunaga3, Norio Yamamoto3, Koichi Omori3, Takayuki Nakagawa4.   

Abstract

In the context of acquired sensorineural hearing loss (SNHL), cochlear hair cells have long been thought to be among the most vulnerable elements in mammalian cochleae. However, recent studies have indicated that the synaptic connection between inner hair cells (IHC) and spiral ganglion neurons (SGN) can be an important target for the treatment of SNHL. Our previous studies in patients with sudden SNHL demonstrated delayed and gradual hearing recovery following topical application of insulin-like growth factor 1 (IGF-1), suggesting that not only protective but also regenerative mechanisms may account for hearing recovery after treatment with IGF-1. We then hypothesized that IGF-1 has the potential to drive the regeneration of IHC-SGN synapses. To test this hypothesis, we investigated the effects of IGF-1 on IHC-SGN synapses using cochlear explant cultures from postnatal day 2 mice that had been damaged by exposure to the excitatory amino acids N-methyl-d-aspartate and kainate. Cochlear explants that lost IHC-SGN synapses upon exposure to excitatory amino acids were cultured with exogenous IGF-1 for an additional 48 h. We observed increased numbers of IHC-SGN synapses after exogenous IGF-1 application. Pharmacological inhibition of the IGF-1 receptor attenuated the restoration of IHC-SGN synapses by exogenous IGF-1. These findings indicated that IGF-1 induces regeneration of IHC-SGN synapses in cochlear explant cultures from postnatal day 2 mice. Therefore, in a future study we will perform in vivo experiments using adult mice to ascertain the effects of IGF-1 on the regeneration of IHC-SGN synapses.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Afferent synapse; Cochlea; Hair cell; Insulin-like growth factor 1; Regeneration; Spiral ganglion neuron

Mesh:

Substances:

Year:  2019        PMID: 30682699     DOI: 10.1016/j.heares.2019.01.008

Source DB:  PubMed          Journal:  Hear Res        ISSN: 0378-5955            Impact factor:   3.208


  6 in total

Review 1.  Neuroprotective role of insulin-like growth factor 1 in auditory and other nervous systems.

Authors:  Kohei Yamahara; Norio Yamamoto; Fumihiko Kuwata; Takayuki Nakagawa
Journal:  Histol Histopathol       Date:  2022-02-16       Impact factor: 2.130

2.  Hearing Dysfunction After Treatment With Teprotumumab for Thyroid Eye Disease.

Authors:  Connie M Sears; Amee D Azad; Linus Amarikwa; Brandon H Pham; Clara J Men; Daniel N Kaplan; Jocelyn Liu; Andrew R Hoffman; Austin Swanson; Jennifer Alyono; Jennifer Y Lee; Chrysoula Dosiou; Andrea L Kossler
Journal:  Am J Ophthalmol       Date:  2022-02-25       Impact factor: 5.488

Review 3.  Hearing loss: The final frontier of pharmacology.

Authors:  Alan C Foster; Bonnie E Jacques; Fabrice Piu
Journal:  Pharmacol Res Perspect       Date:  2022-06

Review 4.  Research Progress on Neuroprotection of Insulin-like Growth Factor-1 towards Glutamate-Induced Neurotoxicity.

Authors:  Lijun Ge; Shuyuan Liu; Limor Rubin; Philip Lazarovici; Wenhua Zheng
Journal:  Cells       Date:  2022-02-14       Impact factor: 6.600

5.  Ultrasound Microbubbles Enhance the Efficacy of Insulin-Like Growth Factor-1 Therapy for the Treatment of Noise-Induced Hearing Loss.

Authors:  Yi-Chun Lin; Yuan-Yung Lin; Hsin-Chien Chen; Chao-Yin Kuo; Ai-Ho Liao; Ying-Liang Chou; Chia-Lien Hung; Cheng-Ping Shih; Chih-Hung Wang
Journal:  Molecules       Date:  2021-06-13       Impact factor: 4.411

6.  Y-27632, a ROCK inhibitor, improved laser-induced shock wave (LISW)-induced cochlear synaptopathy in mice.

Authors:  Yutaka Koizumi; Kunio Mizutari; Satoko Kawauchi; Shunichi Sato; Akihiro Shiotani; Seiji Kakehata
Journal:  Mol Brain       Date:  2021-07-03       Impact factor: 4.041

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.